Bayer Askbio Advances Gene Therapy Clinical Trial Limb-Girdle Muscular Dystrophy

 

• Data Safety Monitoring Board (DSMB) recommendation to initiate second cohort follows review of Phase 1/Phase 2 LION-CS101 trial safety data for AB-1003
• Second cohort enrollment is ongoing

https://www.globenewswire.com/news-release/2025/03/07/3038903/0/en/AskBio-Advances-Gene-Therapy-Clinical-Trial-for-Limb-Girdle-Muscular-Dystrophy-Type-2I-R9-with-Dosing-of-First-Participant-in-Second-Cohort.html